Discover 818 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 818
Active & Responsive
Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
for
Osteoarthritis (OA) of the Knee, Physiotherapy, Pharmacy
Location: Sherwood Park
Sponsor: University of Alberta
Sex: All
Age: 50+
Code: NCT06681142
Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Kentville, Boston MA, Providence RI, Levis,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase 3, Recruiting
Active & Responsive
Effect of Hi-OxSR for the Treatment of Post COVID Condition
for
Long COVID, Post COVID-19 Condition,
Location: Sherbrooke, Toronto, Edmonton
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT06928506
Recruiting
Active & Responsive
Predictors of Relapse in Major Depressive Disorder (PERFORM-D)
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
for
Sleep Apnea, Obstructive
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT05497180
Phase 1, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: North Dartmouth MA, Fall River MA, Quebec, Flushing NY,
Sponsor: Pfizer
Sex: All
Age: 35 - 70+
Code: NCT07363694
Phase 2, Phase 3, Recruiting
Active & Responsive
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Boston MA, The Bronx NY, Montreal, Syracuse NY, Toronto,
Sponsor: Alessandro Doria
Sex: All
Age: 18 - 70+
Code: NCT06217302
Phase 3, Recruiting
Active & Responsive
Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies
for
Diabetes Mellitus, Hypertension, Hyperlipidaemia
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT07339852
Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: The Bronx NY, Quebec, Norfolk VA, Rockville MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase 2, Recruiting
Active & Responsive
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Boston MA, Burlington MA, Farmington CT, Lebanon NH,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase 2, Phase 3, Recruiting
Active & Responsive
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)